Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Salivary Gland Neoplasms × Axitinib × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 21 Neoplasms 7 Kidney Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Carcinoma 5 Melanoma 4 Lung Neoplasms 4 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Thyroid Neoplasms 2 Kidney Diseases 2 Clear-cell metastatic renal cell carcinoma 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Glioblastoma 1

Interventions

Cetuximab 3 Vorinostat 2 Radiosurgery 2 Nivolumab 2 Ipilimumab 2 Dasatinib 2 Cisplatin 2 Bevacizumab 2 temsirolimus 1 pembrolizumab 1 ispinesib 1 eribulin 1 dehydroftorafur 1 apalutamide 1 alectinib 1 Sorafenib 1 Sirolimus 1 Platinum 1 Pilocarpine 1 Oral Hygiene 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Moxibustion 1 Magnetic Resonance Spectroscopy 1 MK 2206 1 Lapatinib 1 Irinotecan 1 Immunoglobulin G 1 Gonadotropin-Releasing Hormone 1 Gemcitabine 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡